BIOCEPT, INC. Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements
BIOCEPT, INC. reported Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements of 215.45 thousand shares for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-11-10.
Discontinued › Notes
us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements · last filed 2023-04-17
- BIOCEPT, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2021-09-30 was 240.94K shares.
- BIOCEPT, INC. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2021-03-31 was 267.71K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 3 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 6 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 9 month |
|---|---|---|---|
| 2022-06-30 | 215.45K shares 10-Q · filed 2022-11-10 | ||
| 2021-09-30 | 240.94K shares 10-Q · filed 2021-11-15 | 240.94K shares 10-Q/A · filed 2023-04-17 | |
| 2021-06-30 | 215.45K shares 10-Q · filed 2021-08-16 | ||
| 2021-03-31 | 267.71K shares 10-Q · filed 2022-05-23 |